# FDA Inspection 1244660 - Gland Pharma Limited, Units I+II Pashamylaram Site - August 02, 2024

Source: https://www.keypedia.com/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/9a9126ce-3d6e-4ad7-891a-5cdd10d186bd
Source feed: FDA_Inspections

> FDA Inspection 1244660 for Gland Pharma Limited, Units I+II Pashamylaram Site on August 02, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1244660
- Company Name: Gland Pharma Limited, Units I+II Pashamylaram Site
- Inspection Date: 2024-08-02
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [FDA Inspection 1216053 - 2023-08-26](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/955ba795-ebdd-4ebb-861f-16909163e529)
- [FDA Inspection 1210478 - 2023-06-27](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/cdefda8a-9fac-4c48-90f1-47b5c117ec07)
- [FDA Inspection 1109239 - 2019-11-07](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/b1e79e8a-4766-4a82-8ce3-2f50924d5757)
- [FDA Inspection 1043371 - 2018-02-23](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/2a89c877-04b5-44c9-bda9-2d69a6bcbb57)
- [FDA Inspection 944183 - 2015-09-18](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited-units-iii-pashamylaram-site/d77a2750-82df-4a46-854c-8ebea4093694)

Company: https://www.keypedia.com/companies/gland-pharma-limited-units-iii-pashamylaram-site/a7dffca3-c5cc-4802-9cab-54995e7133ca

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8